Ichnos enters licensing agreement with Astria for antagonist monoclonal antibody Portfolio
Telazorlimab is a novel, humanized IgG1 monoclonal antibody that targets OX40 on T-cells responsible for inflammation and immunity diseases.
Ichnos enters licensing agreement with Astria for antagonist monoclonal antibody Portfolio Read More